metamizole + caffeine + propyphenazone + diclofenac + morphine

This is a **combination drug** consisting of metamizole, caffeine, propyphenazone, diclofenac, and morphine. - **Metamizole** is a non-opioid analgesic and antipyretic commonly used for the management of severe pain and fever; it inhibits prostaglandin synthesis mainly via cyclooxygenase (COX) inhibition[3][6]. - **Caffeine** is a central nervous system stimulant that enhances alertness and can potentiate the analgesic effects of other agents, mainly by antagonizing adenosine receptors[1]. - **Propyphenazone** is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties, often used in combination with other analgesics; it inhibits cyclooxygenase enzymes[7]. - **Diclofenac** is a widely used NSAID with anti-inflammatory, analgesic, and antipyretic effects, acting as a non-selective inhibitor of cyclooxygenase (COX-1 and COX-2). - **Morphine** is an opioid analgesic used for the treatment of moderate to severe pain, exerting its effects primarily via agonism at the mu-opioid receptor. This combination, as a five-drug fixed preparation, does not appear to be a recognized standard pharmaceutical product. However, each component is well-established in clinical use individually or in various other combinations for the management of pain, particularly when pain is acute, severe, or refractory to monotherapy.